Back To: Home

CLICK HERE FOR WHAT'S NEW IN:
 




 

New year, new business
March 2019
SHARING OPTIONS:

LONDON—Quanticate announced early this year that it had launched QVigilance as a dedicated pharmacovigilance (PV) and risk management business geared toward small and mid-size companies that are moving from clinical trials to post-marketing. Quanticate offers a variety of pharmacovigilance services, including case processing and reporting; global and local literature screening; aggregate production and reporting; signal and risk management; and regulatory intelligence and guidance for regional markets.
 
“It is a natural progression for Quanticate to expand its capabilities through the launch of a company dedicated to delivering PV services,” said David Hukin, managing director of QVigilance. “It’s an area where we have always supported clients, and we have the expertise and experience required to contribute to their continued success.”

Back



PAGE UTILITIES


CONTACT US
DDNEWS
Published by Old River Publications LLC
19035 Old Detroit Road
Rocky River, OH USA 44116
Ph: 440-331-6600  |  Fax: 440-331-7563
 
© Copyright 2019 Old River Publications LLC. All righs reserved.  |  Web site managed and designed by OffWhite.